| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 243 | 280 | 294 | 345 | 331 | 376 | 390 | 443 | 518 | 589 | 666 | 806 |
| Expenses | 228 | 256 | 266 | 306 | 297 | 316 | 319 | 354 | 410 | 454 | 494 | 517 |
| EBITDA | 15 | 24 | 28 | 39 | 34 | 60 | 71 | 89 | 108 | 135 | 172 | 288 |
| Operating Profit % | 6 % | 8 % | 9 % | 11 % | 10 % | 16 % | 18 % | 20 % | 20 % | 22 % | 24 % | 22 % |
| Depreciation | 11 | 10 | 11 | 14 | 15 | 16 | 17 | 16 | 16 | 17 | 21 | 21 |
| Interest | 3 | 3 | 3 | 4 | 4 | 2 | 1 | 1 | 0 | 0 | 1 | 1 |
| Profit Before Tax | 1 | 12 | 15 | 20 | 15 | 37 | 54 | 73 | 92 | 118 | 233 | 267 |
| Tax | 0 | 0 | 3 | 7 | 4 | 7 | 14 | 22 | 24 | 30 | 50 | 50 |
| Net Profit | 1 | 12 | 12 | 14 | 11 | 29 | 40 | 52 | 68 | 88 | 183 | 215 |
| EPS in ₹ | 0.60 | 7.03 | 12.70 | 8.13 | 6.54 | 17.54 | 24.19 | 31.13 | 40.90 | 53.01 | 110.80 | 130.30 |
RPG Life Sciences
RPG Life Sciences
2,277.80
-28.20
(-1.22%)
Key Fundamentals
Market Cap
3,767.30 Cr
EPS
110.80
PE Ratio
20.60
Dividend Yield
1.05 %
Industry
Healthcare 52 Week High
2,914.00
52 Week Low
1,835.00
PB Ratio
7.10
Debt to Equity
0.00
Sector
Pharmaceuticals Actual
Company News
View All News
RPG Life Sciences Plans Growth Through New Molecules, U.S. Market Entry, and API Capacity Expansion
7 hours ago
7 hours agoRPG Life Sciences is positioning itself for sustained growth through multiple strategic initiatives. The company is launching new molecules and preparing to enter the U.S. market. Additionally, RPG Life Sciences plans to double its API (Active Pharmaceutical Ingredient) capacity as part of efforts to strengthen its global pharmaceutical presence.
RPG Life achieved 13.5% growth in domestic formulations during H1 FY26, significantly outperforming the Indian pharmaceutical market's 7.4% growth rate for the same period. The company's domestic formulations business demonstrated strong performance compared to the broader industry benchmark.
RPG Life Sciences announced its unaudited financial results for the quarter and six months ended September 30, 2025. The company reported revenue from operations of Rs. 18,168 lakhs for the quarter, with profit for the period at Rs. 3,685 lakhs. Earnings per share stood at Rs. 22.28. The company also announced the resignation of Chief Financial Officer Vishal Shah, effective October 23, 2025, citing personal reasons. Shah expressed gratitude for his tenure and the company's transformation journey. RPG Life Sciences is in the process of identifying a suitable replacement for the CFO position. The results include exceptional items of Rs. 1,122 lakhs related to insurance proceeds from a fire incident that occurred at one of the company's manufacturing blocks in January 2025.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,679.10 | #1 3,98,049.70 | 38.75 | #1 54,729.00 | 9.71 | #1 10,980 | -19.84 | 61.71 | |
6,621.50 | 1,75,222.50 | 76.19 | 9,712.00 | 18.67 | 2,191 | 26.74 | 72.60 | |
1,577.60 | 1,26,768.90 | 23.67 | 28,409.50 | 7.12 | 5,291 | 9.88 | 60.63 | |
3,584.30 | 1,19,599.80 | 60.49 | 11,539.40 | 6.99 | 1,911 | 19.91 | 53.74 | |
1,255.90 | 1,03,508.80 | #1 18.25 | 33,741.20 | 16.73 | 5,725 | 1.26 | 48.97 | |
2,476.60 | 1,01,344.60 | 53.48 | 12,744.20 | #1 20.90 | 2,007 | -18.14 | 47.04 | |
987.65 | 99,073.80 | 21.09 | 23,511.00 | 18.55 | 4,615 | 2.60 | 45.37 | |
1,940.00 | 89,121.90 | 23.79 | 22,909.50 | 13.74 | 3,306 | #1 51.64 | 46.82 | |
5,581.50 | 66,047.70 | 28.61 | 13,458.30 | 3.70 | 2,216 | 21.39 | 63.11 | |
1,101.00 | 64,254.10 | 19.04 | 32,345.60 | 9.43 | 3,484 | -10.24 | 50.87 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
13.03 %
Net Income Growth
108.89 %
Cash Flow Change
-17.49 %
ROE
47.67 %
ROCE
40.14 %
EBITDA Margin (Avg.)
12.63 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 197 | 205 | 247 | 291 | 251 | 267 | 303 | 345 | 419 | 513 | 658 |
| Fixed Assets | 105 | 109 | 137 | 131 | 128 | 123 | 113 | 104 | 124 | 114 | 172 |
| Current Assets | 86 | 87 | 96 | 143 | 97 | 126 | 176 | 207 | 264 | 298 | 465 |
| Capital Work in Progress | 1 | 2 | 2 | 9 | 17 | 10 | 12 | 31 | 25 | 96 | 16 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 58 | 91 | 127 |
| Other Assets | 92 | 94 | 108 | 152 | 106 | 134 | 178 | 210 | 211 | 212 | 343 |
| Total Liabilities | 197 | 205 | 247 | 291 | 251 | 267 | 303 | 345 | 419 | 513 | 658 |
| Current Liabilities | 67 | 67 | 79 | 121 | 78 | 83 | 80 | 80 | 103 | 131 | 120 |
| Non Current Liabilities | 5 | 5 | 21 | 16 | 13 | 8 | 7 | 9 | 9 | 7 | 7 |
| Total Equity | 125 | 134 | 147 | 155 | 161 | 177 | 216 | 256 | 308 | 375 | 531 |
| Reserve & Surplus | 112 | 120 | 134 | 142 | 147 | 163 | 203 | 243 | 294 | 362 | 517 |
| Share Capital | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 0 | 1 | -1 | 0 | 0 | 40 | 17 | -32 | -5 | 9 |
| Investing Activities | -10 | -15 | -30 | -16 | -19 | -11 | -8 | -35 | -106 | -79 | -42 |
| Operating Activities | -2 | 33 | 7 | 15 | 46 | 50 | 58 | 65 | 91 | 94 | 78 |
| Financing Activities | 12 | -18 | 23 | 0 | -27 | -39 | -11 | -14 | -17 | -20 | -27 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 72.07 % | 72.07 % | 72.07 % | 72.07 % | 72.07 % | 72.41 % | 72.61 % | 72.61 % | 72.81 % | 72.81 % | 72.81 % | 72.81 % | 72.81 % | 72.81 % | 72.81 % | 72.95 % | 72.95 % | 72.95 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.46 % | 0.56 % | 0.89 % | 1.14 % | 1.35 % | 1.30 % | 1.45 % | 1.35 % |
| DIIs | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 2.04 % | 2.02 % | 2.12 % | 2.29 % | 3.59 % | 3.79 % | 4.19 % | 4.63 % | 5.45 % | 6.06 % | 6.14 % | 6.48 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 20.45 % | 20.59 % | 20.58 % | 20.65 % | 20.85 % | 20.37 % | 19.91 % | 20.26 % | 19.91 % | 19.45 % | 18.41 % | 18.16 % | 17.41 % | 16.79 % | 15.92 % | 15.58 % | 15.33 % | 15.46 % |
| Others | 7.47 % | 7.33 % | 7.34 % | 7.28 % | 7.07 % | 7.21 % | 5.44 % | 5.10 % | 5.16 % | 5.45 % | 4.73 % | 4.67 % | 4.70 % | 4.62 % | 4.47 % | 4.11 % | 4.12 % | 3.76 % |
| No of Share Holders | 18,701 | 20,564 | 23,674 | 22,768 | 22,821 | 22,115 | 20,757 | 21,360 | 20,837 | 20,226 | 21,088 | 21,866 | 22,137 | 22,232 | 23,481 | 24,891 | 24,867 | 25,832 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 2.8 | 2.4 | 2.4 | 4 | 7.2 | 9.6 | 12 | 16 | 24 |
| Dividend Yield (%) | 0.00 | 0.73 | 0.97 | 1.41 | 1.03 | 1.28 | 1.4 | 0.79 | 0.7 | 1.04 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 17 Oct 2025 |  Quarterly Result Announcement | NA | 17 Oct 2025 | 2,234.25 | 2,306.00 |
| 17 Aug 2021 |  Dividend | ₹ 7.20 /share | 13 Aug 2021 | 490.80 | 516.85 |
| 15 Jul 2022 | Dividend | ₹ 9.60 /share | 14 Jul 2022 | 589.35 | 568.55 |
| 21 Jul 2023 | Dividend | ₹ 12.00 /share | 21 Jul 2023 | 820.55 | 996.65 |
| 28 Jun 2024 | Dividend | ₹ 16.00 /share | 28 Jun 2024 | 1,560.55 | 1,599.95 |
| 16 Jul 2024 |  Annual General Meeting | NA | 16 Jul 2024 | 1,535.60 | 1,640.55 |
| 07 Nov 2024 | Quarterly Result Announcement | NA | 07 Nov 2024 | 2,443.95 | 2,673.90 |
| 24 Jan 2025 | Quarterly Result Announcement | NA | 24 Jan 2025 | 2,067.10 | 2,166.65 |
| 28 Apr 2025 | Quarterly Result Announcement | NA | 28 Apr 2025 | 2,197.25 | 2,244.30 |
| 27 Jun 2025 | Dividend | ₹ 4.00 /share | 27 Jun 2025 | 2,244.30 | 2,424.10 |
| 27 Jun 2025 | Dividend | ₹ 20.00 /share | 27 Jun 2025 | 2,244.30 | 2,424.10 |
| 16 Jul 2025 | Annual General Meeting | NA | 16 Jul 2025 | 2,341.50 | 2,557.00 |
| 25 Jul 2025 | Quarterly Result Announcement | NA | 25 Jul 2025 | 2,548.80 | 2,515.25 |
Announcements
Announcement under Regulation 30 (LODR)-Press Release / Media Release8 hours ago
8 hours agoAnnouncement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)10 hours ago
10 hours agoAnnouncement under Regulation 30 (LODR)-Investor Presentation11 hours ago
11 hours agoRPG Life Sciences Limited Has Submitted To The Exchange The Financial Results For The Quarter And Half Year Ended September 30 2025.11 hours ago
11 hours agoBoard Meeting Outcome for Outcome Of Board Meeting Held On October 17 202511 hours ago
11 hours agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation3 days ago
3 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation4 days ago
4 days agoCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20187 days ago
7 days agoBoard Meeting Intimation for Board Meeting Intimation For RPG Life Sciences Limited To Consider And Approve Unaudited Financial Results For The Quarter And Half Year Ended September 30 20257 days ago
7 days agoClosure of Trading WindowSep 25, 2025
Sep 25, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 17, 2025
Sep 17, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 01, 2025
Sep 01, 2025Intimation Regarding 100 Days Campaign - "Saksham Niveshak"Aug 20, 2025
Aug 20, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 18, 2025
Aug 18, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 26, 2025
Jul 26, 2025Amendment In Policy Of The CompanyJul 25, 2025
Jul 25, 2025Announcement under Regulation 30 (LODR)-Investor PresentationJul 25, 2025
Jul 25, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJul 25, 2025
Jul 25, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 25, 2025
Jul 25, 2025Unaudited Financial Result For The Quarter Ended On June 30 2025Jul 25, 2025
Jul 25, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On July 25 2025Jul 25, 2025
Jul 25, 2025Board Meeting Intimation for Board Meeting Intimation To Consider And Approve Unaudited Financial Results For The Quarter Ended June 30 2025Jul 18, 2025
Jul 18, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 18, 2025
Jul 18, 2025Voting Result Of 18Th Annual General MeetingJul 16, 2025
Jul 16, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportJul 16, 2025
Jul 16, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMJul 16, 2025
Jul 16, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2025
Jul 14, 2025Closure of Trading WindowJun 25, 2025
Jun 25, 2025 Intimation Under Regulation 30 Regarding Letter Dispatched To The Shareholders Of The CompanyJun 24, 2025
Jun 24, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 24, 2025
Jun 24, 2025Business Responsibility and Sustainability Reporting (BRSR)Jun 23, 2025
Jun 23, 2025Reg. 34 (1) Annual Report.Jun 23, 2025
Jun 23, 2025Notice Of 18Th Annual General Meeting Scheduled On Wednesday July 16 2025.Jun 23, 2025
Jun 23, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 16, 2025
Jun 16, 2025Intimation Of Record Date For 18Th AGM Of The Company Scheduled On July 16 2025.
Jun 14, 2025
Jun 14, 2025 Email Communication To Shareholders Regarding Dividend Taxation ProvisionsJun 05, 2025
Jun 05, 2025Further To Our Letter Dated April 28 2025 We Enclose Herewith Updated Annexure C Pursuant To Details Required As Per SEBI Circular No. SEBI/HO/CFD/CFD-Pod-1/P/CIR/2023/123 Dated July 132023.Jun 03, 2025
Jun 03, 2025Intimation To Shareholders Holding Shares In Physical Mode Regarding Furnishing Of PAN KYC Details And NominationJun 03, 2025
Jun 03, 2025Announcement under Regulation 30 (LODR)-Investor PresentationJun 02, 2025
Jun 02, 2025In Accordance With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations") To Shareholders Whose Shares Are Liable To Be Transferred To IEPF Authority.Jun 01, 2025
Jun 01, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 29, 2025
May 29, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 23, 2025
May 23, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 05, 2025
May 05, 2025Earning Call Audio Recording Link For Q$ Ended On March 31 2025.Apr 29, 2025
Apr 29, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 29, 2025
Apr 29, 2025Announcement under Regulation 30 (LODR)-Investor PresentationApr 29, 2025
Apr 29, 2025Amendment Of PoliciesApr 28, 2025
Apr 28, 2025Disclosure Under 30(5) Of SEBI (Listing Obligations And Disclosure Requirement) Regulations 2015Apr 28, 2025
Apr 28, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 28, 2025
Apr 28, 2025Corporate Action-Board approves DividendApr 28, 2025
Apr 28, 2025Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Unifi Flexi Cap Fund Direct-Growth | 1.00% | 1500 | 0.16% | 0.10% | |
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.07% | -2 | -0.01% | -0.01% | |
 Mirae Asset Multicap Fund Direct - Growth | 0.76% | 0 | -0.06% | -0.09% | |
 Motilal Oswal Quant Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% | |
 Quant Healthcare Fund Direct - Growth | 8.88% | 0 | -0.22% | 0.04% | |
| Quant Multi Cap Fund Direct-Growth | 0.43% | 0 | -0.02% | -0.01% | |
 Union Small Cap Fund Direct-Growth | 0.73% | 0 | -0.05% | -0.06% | |
 WhiteOak Capital Pharma and Healthcare Fund Direct - Growth | 0.00% | 0 | 0.00% | 0.00% |
Technical Indicators
RSI(14)
Neutral 47.95
ATR(14)
Less Volatile 60.22
STOCH(9,6)
Neutral 56.02
STOCH RSI(14)
Neutral 74.04
MACD(12,26)
Bullish 2.32
ADX(14)
Weak Trend 14.59
UO(9)
Bearish 45.40
ROC(12)
Uptrend And Accelerating 2.75
WillR(14)
Neutral -53.11
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
